Researchers at Stanford University have formulated a novel biomaterial suitable for three-dimensional (3D) bioprinting: a homogeneous composite of polycaprolactone (PCL), gelatin, and beta-tricalcium phosphate.
Based on their proprietary HyTEC tissue engineering platform, researchers at Stanford have developed an osteoinductive intramedullary implant (IM) device for improved bone healing.